Independent directory Public ClinicalTrials.gov records United States
ClinicalTrials.gov record
Completed Phase 3 Interventional Results available

The Efficacy and Safety of Oral Azacitidine Plus Best Supportive Care Versus Placebo and Best Supportive Care in Subjects With Red Blood Cell (RBC) Transfusion-Dependent Anemia and Thrombocytopenia Due to International Prognostic Scoring System (IPSS) Low Risk Myelodysplastic Syndrome (MDS)

ClinicalTrials.gov ID: NCT01566695

Public ClinicalTrials.gov record NCT01566695. Field values are reproduced from the official study page; the official ClinicalTrials.gov record remains the source of truth for eligibility, enrollment, and contact information.

ClinicalTrials.gov public records Last synced Jul 20, 2026, 12:29 AM EDT

Data is sourced from official ClinicalTrials.gov public API records. Always review the official ClinicalTrials.gov record for the latest information.

Official title

A Phase 3, Multicenter, Randomized, Double-blind Study to Compare the Efficacy and Safety of Oral Azacitidine Plus Best Supportive Care Versus Placebo Plus Best Supportive Care in Subjects With Red Blood Cell Transfusion-dependent Anemia and Thrombocytopenia Due to IPSS Lower-risk Myelodysplastic Syndromes.

Study identification

NCT ID
NCT01566695
Recruitment status
Completed
Study type
Interventional
Phase
Phase 3
Lead sponsor
Celgene
Industry
Enrollment
216 participants

Conditions and interventions

Interventions

  • Oral Azacitidine Drug
  • Placebo Drug
  • Best Supportiv Care (BSC) Other

Drug · Other

Eligibility (public fields only)

Age range
18 Years and older
Sex
All
Healthy volunteers
Healthy volunteers not accepted

This page does not interpret eligibility. Detailed inclusion and exclusion criteria are on the official ClinicalTrials.gov record.

Study timeline

Start date
Apr 25, 2013
Primary completion
Jan 24, 2019
Completion
Dec 20, 2023
Last update posted
Jan 6, 2025

2013 – 2023

United States locations

U.S. sites
40
U.S. states
23
U.S. cities
34
Facility City State ZIP Site status
Alta Bates Comprehensive Cancer Center Berkeley California 94704
Tower Hematology/Oncology Medical Group and Tower Cancer Research Found Beverly Hills California 90211
City Of Hope Duarte California 91010-301
California Cancer Associates for Research and Excellence cCARE Escondido California 92025
Marin Oncology Associates Greenbrae California 94904-2007
UCSD-Thornton Hospital La Jolla California 92093-0943
University of Southern California Norris Cancer Center Los Angeles California 90033
Local Institution - 942 New Haven Connecticut 06519
University of Florida Health Cancer Center at Orlando Health Orlando Florida 32806
Phoebe Cancer Center of Phoebe Putney Memorial Hospital Albany Georgia 31701
Robert H Lurie Comprehensive Cancer Center NW Univ Chicago Illinois 60611
University Of Illinois At Chicago Chicago Illinois 60612
University Of Chicago Medical Center Chicago Illinois 60637
Loyola University Chicago Maywood Illinois 60153
University Of Kansas Medical Center Kansas City Kansas 66160-7233
University of Louisville, J.G. Brown Cancer Center Louisville Kentucky 40202
Hematology And Oncology Specialists, Llc Metairie Louisiana 70006
Johns Hopkins Medicine Baltimore Maryland 21231
UMASS Memorial Hospital Worcester Massachusetts 01655
Mayo Clinic Rochester Minnesota 55905
Jackson Oncology Associates PLLC Jackson Mississippi 39202
Saint Luke's Cancer Institute Kansas City Missouri 64111
Kansas City VA Medical Center University of Kansas Medical Center Kansas City Missouri 64128
University Of Nebraska Medical Center Omaha Nebraska 68198-6805
Weill Cornell Medical College - New York - Presbyterian Hospital New York New York 10021
Icahn School of Medicine at Mount Sinai Medical Center New York New York 10029
Levine Cancer Institute Charlotte North Carolina 28204
Eastern Institute of Medical Sciences Greenville North Carolina 27834
University Hospitals of Cleveland Case Medical Center Cleveland Ohio 44106-5000
Ohio State University Medical Center Columbus Ohio 43210
Local Institution - 917 Portland Oregon 97227
Penn Medicine: University of Pennsylvania Health System Philadelphia Pennsylvania 19104
Western Pennsylvania Cancer Institute Pittsburgh Pennsylvania 15224
Brooke Army Medical Center Francis Street Medical Center Fort Sam Houston Texas 78235-8200
Local Institution - 900 Houston Texas 77030
Local Institution - 924 Houston Texas 77030
Millennium Physicians - Oncology Houston Texas 77090
VA Commonwealth University - Massey Cancer Center Richmond Virginia 23298-0037
Local Institution - 904 Seattle Washington 98109-4417
Waukesha Memorial Hospital Waukesha Wisconsin 53188-5099

Site contact phone numbers, emails, and investigator names are intentionally not displayed here. Open the official ClinicalTrials.gov record for site contact information.

Non-U.S. locations

This page focuses on the U.S. directory. The official record also lists 156 non-U.S. sites.

About this trial record page

What this page shows
Public field values for ClinicalTrials.gov record NCT01566695, including study identification, conditions, interventions, eligibility (age, sex, healthy volunteer), timeline, and U.S. site list.
What this page does not do
No medical advice, eligibility judgments, treatment recommendations, study quality scoring, or AI-generated medical summaries. No site contact phone numbers, emails, or investigator names.
Where the data comes from
Sourced from the official ClinicalTrials.gov public API. The official record is the source of truth.
Last refresh
Last update posted Jan 6, 2025 · Synced Jul 20, 2026

Related: full search, browse by condition, browse by drug or therapy, browse by sponsor, browse by U.S. city.

Open the official record

The complete protocol, eligibility criteria, and contact information for NCT01566695 live on ClinicalTrials.gov.

View official ClinicalTrials.gov record →